Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease;Implication du polymorphisme génétique de l'apolippprotéine E et de l'enzyme de conversion de l'angiotensine dans l'athérosclérose coronarienne

Annales de Biologie Clinique

Volumn 62, Issue 3, 2004, Pages 295-304

  Bennouar, N ^a,b   Allami, A ^a,c   Laraqui, A ^a,d   Azeddoug, H ^b   El Kadiri, N ^a   Benkouka, F ^d   Bendriss, A ^c   Ghannam, R ^a   Benomar, A ^a   Fellat, S ^a   Benomar, M ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b FACULTÉ DES SCIENCES AIN CHOCK   (Morocco)

^c ABDELMALEK ESSAADI UNIVERSITY   (Morocco)

^d FACULTÉ DES SCIENCES   (Morocco)

Author keywords

Angiotensin converting enzyme; Apo E; Atherosclerosis; Genetic polymorphism; Risk factor

Indexed keywords

EID: 2542586329     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Couderc R, Bailleul S. L'apolipoprotéine E et ses allèles chez le sujet sain et au cours de l'athérosclérose. Ann Biol Clin 1998 ; 56 : 651-9.
2. Paik YK, Chang DJ, Readon CA, et al. Nucleotide sequence and structure of human apolipoprotein E gene. Proc Natl Acad Sci USA 1985 ; 82 : 3445-9.
3. Zannis VI, Breslow JL, Utermann G, et al. Proposed nomenclature of apo E isoproteins, apo E genotypes and phenotypes. J Lipid Res 1982 ; 23 : 911-4.
4. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res 1992 ; 33 : 447-54.
5. Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL. Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci USA 1984 ; 81 : 5566-70.
6. Wilson PW F, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. Arterioscler Thromb Vasc Biol 1996 ; 16 : 1250-5.
7. Birgit A, Børge G, Nordestgaard RS. ACE gene polymorphism: ischemic heart disease and longevity in 10 150 individuals. A case-referent and retrospective cohort study based on the Copenhagen city heart study. Circulation 1997 ; 95 : 2358-67.
8. Girerd X, Hanon O, Mourad JJ, Boutouyrie P, Laurent S, Jeunemaitre X. Lack of association between renin-angiotensin system, gene polymorphisms and wall thickness of the radial and carotid arteries. Hypertension 1998 ; 32 : 579-83.
9. Ludwig E, Cornell PS, Anderson JL, Marshall HW, Labouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995 ; 91 : 2120-4.
10. Lagarde JP, Benlian P, Zekraoui L, Raisonnier A. Génotypage de l'apolipoprotéine E (allèles ε2, ε3 et ε4) à partir du sang capillaire. Ann Biol Clin 1995 ; 53 : 15-20.
11. Koch W, Kastralui A, Mehilli J, Böttiger C, Von Beckerath N, Schömig A. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 2000 ; 102 : 197-202.
12. Tiret I, De Knijff P, Menzel HJ, Ehnholm CH, Nicaud V, Havekes L. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. Arterioscler Thromb 1994 ; 14 : 1617-24.
13. Senti M, Nogués X, Pedro-Botet J, Rubiés-Prat J, Vidal-Barraquer F. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apolipoprotein E phenotypes. Circulation 1992 ; 85 : 30-5.
14. Ordovas JM, Löpez-Miranda J, Pérez-Jiménez F, Rodriguez CR, Park J, Cole T. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG-CoA reductase inhibitor therapy. Atherosclerosis 1995 ; 113 : 157-66.
15. Lambert JC, Brousseau T, Defosse V, et al. Independent association of an apo E gene promoter polymorphism with increased risk of myocardial infarction and decreased apo E plasma concentrations - The ECTIM study. Hum Mol Genet 2000 ; 9 : 57-61.
16. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988 ; 8 : 1-21.
17. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. J Clin Invest 1987 ; 80 : 578-81.
18. Kardia SL, Haviland MB, Ferrell RE, Sing CF. The relationship between risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 1999 ; 19 : 427-35.
19. Mahley RW, Rall SC. Type III hyperlipoproteinemia (dysbetalipoproteinemia) : the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In : Scriver CR, Beaudet AL, Sly WS, Valla D, eds. The metabolic and molecular bases of inherited disease. 7th Ed. New York : Mc Graw-Hill, 1995 : 1953-80.
20. Frikke-Schmidt R, Tybjaerg-Hansen A, Steffensen R, Jensen G, Nordestgaard BG. Apolipoprotein E genotype : epsilon 32 women are protected while epsilon 43 and 44 men are susceptible to ischemic heart disease. J Am Coll Cardiol 2000 ; 35 : 1192-9.
21. Hagberg JM, Wilund KR, Ferrell RE. Apo E gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics 2000 ; 4 : 101-8.
22. Parra HJ, Arveiler D, Evans AE, et al. A case-controle study of lipoprotein particles in two populations at contrasting risk for coronary heart disease : the ECTIM study. Arterioscl Thromb 1992 ; 12 : 701-7.
23. Cambien F, Poirier O, Lecerf L, et al. Detection polumorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992 ; 359 : 641-4.
24. Lindpaintner K, Lee M, Larson MG, et al. Absence of association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass. N Engl J Med 1996 ; 334 : 1023-8.
25. Keidar S, Attias J, Heinrich R, Coleman R, Aviram M. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis 1999 ; 146 : 249-57.
26. Masahiro S, Naoki M, Takashi Y. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol - fed rabbits. Atherosclerosis 1996 ; 127 : 123-9.
27. O'Malley JP, Maslen CL, Illingworth DR. Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia. Circulation 1998 ; 97 : 1780-3.
28. Anderson KM, Wilson PWF, Odell PM, Kannel WB. Framingham heart study coronary heart disease risk reduction chart - and updated coronary risk profile. In : Gold P, Grover S, Roncari D, eds. Cholesterol and CHD. Perkridge : The Parthenon Publishing Group, 1992 : 3-17.
29. Van Bockxmeer PM, Mamotte CDS, Gibbons PA, Burke V, Taylor RR. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation 1995 ; 92 : 2066-71.